Active
A placebo-controlled study of saracatinib (AZD0530) in patients with recurrent osteosarcoma localized to the lung
Type of Sarcoma:
Osteosarcoma
Drug:
saracatinib and placebo
Accrual Status:
Open, Not Accruing
Overall Study Principal Investigator:
Melinda Merchant, MD, PhD
Staff Clinician, Pediatric Oncology Branch
National Cancer Institute